Curating a Knowledge Base for Individuals with Coinfection of HIV and SARS-CoV-2: EHR-based Data Mining

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 5R21AI170171-02

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2022.0
    2025.0
  • Known Financial Commitments (USD)

    $185,676
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    . Xiaoming Li
  • Research Location

    United States of America
  • Lead Research Institution

    UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Individuals with multimorbidityOther

  • Occupations of Interest

    Unspecified

Abstract

PROJECT SUMMARY The COVID-19 pandemic has cast a heavy burden on individuals with HIV infection. Based on data of 15,522 hospitalized patients with the coinfection of HIV and SARS-CoV-2 from 24 countries, a recent World Health Organization (WHO) report for the first time confirmed that HIV to be an independent risk factor for severe COVID-19. Despite a generally high risk of severe COVID-19 clinical course in individuals with HIV, the interactions between SARS-CoV-2 and HIV infections remain unclear. For example, the severity of COVID-19 in individuals with HIV is correlated with certain comorbidities in which some of these comorbidities are more prevalent in patients with HIV than other populations. Yet, several contradictory findings suggested the predominant role of comorbidities in the severity of COVID-19 regardless of HIV infection. Individuals with low CD4+ T-cell count (e.g., <200~500 cells/µL) and unsuppressed viral load are associated with severe clinical course, yet the role of antiretroviral therapy (ART) exposure and adherence in the context of COVID-19 exposure needs to be examined. Risk factors for the severe clinical course of the coinfection are undetermined because individuals with the same or similar severity level of COVID-19 show different clinical characteristics. To fill address these knowledge gaps, this study will establish an EHR-based cohort for individuals with HIV/SARS- CoV-2 coinfection and develop large-scale EHR-based data mining to examine the interactions between HIV and SARS-CoV-2 infections and systematically identify and validate factors contributing to the severe clinical course of the coinfection. Ultimately, collected clinical evidence will be implemented and used to pilot test a Clinical Decision Support (CDS) prototype to assist providers in screening and referral of at-risk patients in real-world clinics.